Novel indolylarylsulfone derivatives as covalent HIV-1 reverse transcriptase inhibitors specifically targeting the drug-resistant mutant Y181C

Ping Gao; Shu Song; Estrella Frutos-Beltrán; Wenxin Li; Bin Sun; Dongwei Kang; Jinmi Zou; Jian Zhang; Christophe Pannecouque; De Clercq Erik; Luis Menéndez‐Arias; Peng Zhan; Xinyong Liu

doi:10.1016/j.bmc.2020.115927

Related publications

Article2023

Exploring novel <scp>HIV</scp>‐1 reverse transcriptase inhibitors with drug‐resistant mutants: A double mutant surprise

Klarissa Hollander, Albert H. Chan, Kathleen M. Frey, Olivia Hunker, Joseph A. Ippolito, Krasimir A. Spasov, Yang-Hui Jimmy Yeh, William L. Jorgensen, Ya‐Chi Ho, Karen S. Anderson

Protein Science

Article2017

Covalent inhibitors for eradication of drug-resistant HIV-1 reverse transcriptase: From design to protein crystallography

Albert H. Chan, Won‐Gil Lee, Krasimir A. Spasov, José A. Cisneros, Shalley N. Kudalkar, Zaritza O. Petrova, Amanda B. Buckingham, Karen S. Anderson, William L. Jorgensen

Proceedings of the National Academy of Sciences

Article2014

Structural modification of diarylpyrimidine derivatives as HIV-1 reverse transcriptase inhibitors

Shuang‐Xi Gu, Yuan‐Yuan Zhu, Fen‐Er Chen, De Clercq Erik, Jan Balzarini, Christophe Pannecouque

Article2022

Identification of Boronate-Containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

Da Feng, Hao Lin, Liyang Jiang, Zhao Wang, Yanying Sun, Zhongxia Zhou, De Clercq Erik, Christophe Pannecouque, Dongwei Kang, Peng Zhan, Xinyong Liu

Article2024

Identification of novel diarylpyrimidine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors against wild-type and K103N mutant viruses

Xiangyi Jiang, Waleed A. Zalloum, Zhen Gao, Jiaojiao Dai, Xiangkai Ji, Minghui Xie, Guanyu Dong, De Clercq Erik, Boshi Huang, Christophe Pannecouque, Peng Zhan, Xinyong Liu